Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Lumbrokinase DLBS1033 on D-Dimer, Interleukin-6, Length of Stay, and Time to Clinical Stability in Patients With Pneumonia, Sepsis, and Hypercoagulability
NCT07892794Phase 2Completed
- Sponsor
- Universitas Sebelas Maret
- Start
- Aug 2025
- Primary completion
- Sep 2025
- Countries
- 1
01
Overview
A Phase 2 trial of DLBS1033 in pneumonia, sepsis, Blood Coagulation Disorders, sponsored by Universitas Sebelas Maret. Started Aug 2025; status: completed.
02
Drugs
DLBS1033
03
Conditions
pneumoniasepsisBlood Coagulation Disorders
Beyond the preview
Go deeper on NCT07892794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07892794.